In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

A groundbreaking clinical trial has revealed that weight-loss injections marketed as Ozempic and Wegovy may significantly ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Ozempic, known for aiding weight loss, could also help in treating alcohol addiction, as a study in JAMA Psychiatry suggests.

Most individuals begin Ozempic at a dose of 0.25 mg once weekly. This small amount allows the body to adapt to the medication. It also helps minimize side effects, like nausea or upset stomach.

Ozempic is primarily used for managing type ... though it’s not a weight loss medication. Starting dose: 0.25 mg weekly for 4 weeks. Gradually increased to a maximum dose of 2.0 mg weekly.

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...